SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAPUTO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.403
EU - Europa 3.152
AS - Asia 1.381
OC - Oceania 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 10.947
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.398
PL - Polonia 1.724
CN - Cina 716
UA - Ucraina 401
IT - Italia 377
TR - Turchia 292
SG - Singapore 259
DE - Germania 253
GB - Regno Unito 148
SE - Svezia 87
FI - Finlandia 67
ID - Indonesia 52
VN - Vietnam 34
BE - Belgio 29
RU - Federazione Russa 19
CZ - Repubblica Ceca 13
FR - Francia 10
IN - India 10
IR - Iran 8
NL - Olanda 8
RO - Romania 7
IE - Irlanda 6
CA - Canada 5
HK - Hong Kong 5
AU - Australia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
ZA - Sudafrica 2
AT - Austria 1
BD - Bangladesh 1
BR - Brasile 1
CH - Svizzera 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
Totale 10.947
Salva come PNG Salva come JPEG
Città #
Warsaw 1.724
Fairfield 948
Woodbridge 759
Houston 549
Ashburn 448
Jacksonville 401
Chandler 369
Seattle 367
Ann Arbor 342
Wilmington 341
Cambridge 328
Izmir 237
Singapore 184
Princeton 173
Ferrara 168
Beijing 163
Nanjing 161
San Diego 107
New York 101
Shanghai 61
Jakarta 52
Milan 47
Los Angeles 45
Boardman 42
Nanchang 41
Shenyang 37
Hebei 36
Dong Ket 34
Jiaxing 33
Santa Clara 33
Tianjin 30
Brussels 29
Changsha 28
Bologna 27
Dearborn 27
Falls Church 24
Norwalk 22
Jinan 21
Mountain View 21
Orange 18
Redwood City 17
San Mateo 15
Kunming 14
Rome 13
Auburn Hills 12
Brno 12
Des Moines 12
London 12
Modena 12
Ningbo 11
Taizhou 10
Ferrara di Monte Baldo 9
Washington 9
San Bonifacio 8
Ardabil 7
Leawood 7
Munich 7
Phoenix 7
Changchun 6
Dublin 6
Hangzhou 6
Lanzhou 6
Monmouth Junction 6
Zhengzhou 6
Addison 5
Augusta 5
Bremen 5
Philadelphia 5
Andover 4
Dronten 4
Guangzhou 4
Hong Kong 4
New Bedfont 4
Toronto 4
Bucharest 3
Chicago 3
Easton 3
Fuzhou 3
Haikou 3
Helsinki 3
Novosibirsk 3
Prescot 3
Pune 3
Tappahannock 3
Amsterdam 2
Anzola 2
Arezzo 2
Borgo Val di Taro 2
Brescia 2
Gorle 2
Hendon 2
Hunedoara 2
Kilburn 2
Monza 2
Padova 2
Redmond 2
Verona 2
Acton 1
Adliswil 1
Auckland 1
Totale 8.911
Salva come PNG Salva come JPEG
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 259
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 249
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 227
HIV-1 tat addresses dendritic cells to induce a predominant th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 213
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS tat-based vaccines 212
Candidate HIV-1 Tat vaccine development: From basic science to clinical trials 212
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: Findings in a cohort of HIV-1 seroconverters 204
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys 201
null 183
null 179
null 167
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 165
Nanoparticles for delivery of a pharmacologically active agent 161
Recombinant herpes simplex virus and uses therefor 154
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 153
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 153
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 140
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 130
Transformation of hamster kidney cells by fragments of BK virus DNA 126
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 124
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 114
null 113
null 110
Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice 109
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 108
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 106
null 104
null 103
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane 102
null 101
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 101
Containment of infection in Tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6Pcy243 101
Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model 98
null 95
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 94
null 94
Episomal DNA of a BK virus variant in a human insulinoma 93
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 93
Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells 92
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 92
null 91
null 90
null 90
null 87
null 86
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 86
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 86
null 85
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells 84
The HIV-1 regulatory genes tat and rev as targets for gene therapy 83
null 83
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes. 83
Complex associates of plasmid DNA and a novel class of block copolymers with PEG and cationic segments as new vectors for gene delivery 83
null 81
null 79
null 79
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination 79
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 76
null 75
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 74
THE TAT GENE AND PROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 74
Expression of hepatitis B surface antigen in human cells by a recombinant BK virus DNA vector 73
null 72
Reexamination of the coding potential of the HTLV-1 pX region 71
Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens 70
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 67
DNA immunization with HIV-1 tat mutated in the transactivation domain induces humoral and cellular immune response against wild-type Tat 67
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) 67
Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells 67
New BK virus episomal vector for complementary DNA expression in human cells 66
Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes 66
Induction of anti-Tat immune response in mice following inoculation of plasmid DNA expressing HIV-tat mutant genes. 64
Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins 64
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 63
Transformation of Hamster kidney cells by a fragment of BK virus DNA containing the entire early region. 63
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles 63
Interaction of Sp1 transcription factor with HIV-1 Tat protein: Looking for cellular partners 63
The HIV-1 tat gene as a target for gene therapy and analysis of its role in cell proliferation. 62
Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication 62
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application 62
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment 62
Induzione di una risposta immune in topi immunizzati con DNA plasmidici codificanti due mutanti transdominanti negativi del gene tat di HIV-1. 61
Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines 61
The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells 60
Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat 59
HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials 58
Formation of oligomeric free BK virus DNA is required for tandem integration of viral genomes into cellular DNA 57
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules 57
The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice 57
The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein 56
Presenza del virus BK in sarcomi di Kaposi. 53
Oncogenicity of BK virus for immunosuppressed hamster 52
null 50
null 49
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines 48
Upregulation of c-fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein 47
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein 47
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 47
null 46
Studi sulle interrelazioni tra il virus BK e i tumori insulinari 46
Totale 9.694
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.602
Totale 53.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.253 0 0 0 404 220 278 262 269 238 332 159 91
2020/20211.767 165 150 142 156 111 153 109 219 72 237 157 96
2021/20221.319 38 111 73 82 29 53 68 114 61 115 106 469
2022/2023933 140 37 54 103 130 118 59 97 113 9 47 26
2023/2024644 63 80 33 23 44 143 25 36 20 17 11 149
2024/2025402 91 70 240 1 0 0 0 0 0 0 0 0
Totale 11.181